Adaptive Biotechnologies (ADPT) Capital Expenditures (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Capital Expenditures of $796000.0 for Q1 2026, down 65.26% sequentially from $2.3 million in Q4 2025, and up 277.25% YoY from $211000.0 in Q1 2025.
Adaptive Biotechnologies (ADPT) Capital Expenditures (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 9 years of Capital Expenditures data on file, last reported at $796000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 277.25% year-over-year to $796000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 28.41% YoY) and the FY2025 annual result came in at $3.0 million, down 19.24% from the prior year.
- Capital Expenditures retreated to $796000.0 in Q1 2026 per ADPT's latest filing, from $2.3 million in the prior quarter.
- The five-year high for Capital Expenditures was $5.0 million in Q2 2023, with the low at -$5.3 million in Q3 2023.
- Average Capital Expenditures over 5 years is $577941.2, with a median of $344000.0 recorded in 2024.
- Year-over-year, Capital Expenditures plunged 696.55% in 2023 and jumped 2763.75% in 2025.
- Adaptive Biotechnologies' Capital Expenditures stood at -$900000.0 in 2022, then soared by 31.0% to -$621000.0 in 2023, then jumped by 112.88% to $80000.0 in 2024, then jumped by 2763.75% to $2.3 million in 2025, then slumped by 65.26% to $796000.0 in 2026.
- Business Quant data shows ADPT's Capital Expenditures at $796000.0 in Q1 2026, $2.3 million in Q4 2025, and $444000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 39.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 376.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 237.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 8.27 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 22.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 76.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 127.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 38.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 17.41 Mn |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | 796,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 796,000.00 |
| Mar 31, 2026 | 796,000.00 |
| Dec 31, 2025 | 2.29 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 30, 2025 | 444,000.00 |
| Sep 30, 2025 | 444,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 211,000.00 |
| Mar 31, 2025 | 211,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Sep 30, 2024 | 344,000.00 |
| Sep 30, 2024 | 344,000.00 |
| Jun 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 2.13 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | -621,000.00 |
| Dec 31, 2023 | -621,000.00 |